What is the current Connected Diagnostics market size?

The current Connected Diagnostics market size is approximately USD 1.2 billion as of 2023.

What are the key drivers of the Connected Diagnostics market?

Key drivers include increasing demand for remote monitoring and rising adoption of digital technologies.

What are the major challenges facing the Connected Diagnostics market?

Major challenges include data security concerns and lack of standardization in connected devices.

Which regions are leading the Connected Diagnostics market?

North America and Europe are leading the market, driven by high adoption rates and favorable regulatory landscapes.

Who are the top companies in the Connected Diagnostics market?

Top companies include major healthcare providers and medical device manufacturers, such as Philips and Medtronic.

What future opportunities exist in the Connected Diagnostics market?

Future opportunities include integration with emerging technologies, such as AI and IoT, to enhance diagnostic capabilities.

How will technology impact the future outlook of the Connected Diagnostics market?

Technology will play a crucial role in shaping the future outlook, with advancements in data analytics and cloud computing.

What is the current regulatory landscape for the Connected Diagnostics market?

The regulatory landscape is evolving, with a focus on ensuring data security and protecting patient privacy.

How will the Connected Diagnostics market size change in the next 5 years?

The market size is expected to increase significantly, driven by growing demand for connected diagnostics solutions.

Connected Diagnostics Market Potential & Strategic Outlook 2033

Connected Diagnostics by Application (/> Clinical Research Organizations (CROs), Clinics, Hospitals, Others), by Type (/> On-Premise, Cloud-Based), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 17.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 17.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Connected Diagnostics Market Size | CAGR 17.2 Forecast 2033

Connected Diagnostics Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 17.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 17.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Connected Diagnostics Market Overview

The Connected Diagnostics market refers to the integration of digital technologies and medical devices to enhance diagnostic capabilities. As the Connected Diagnostics market size is expected to reach $24.1 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various segments, including Point-of-Care diagnostics, In-Vitro diagnostics, and Imaging diagnostics, which are driving the demand for connected diagnostic solutions. The current market size is approximately $15.6 billion, with a CAGR of 8.5% from 2021 to 2025.

Loading chart…

The growth forecast for the Connected Diagnostics market is driven by key forces such as technology shifts towards digitalization, regulatory requirements for data security, and consumer behavior demanding personalized healthcare. The largest region for Connected Diagnostics is currently North America, while the fastest-growing region is expected to be the Asia-Pacific. As the market continues to evolve, macro drivers such as increasing healthcare expenditure and the need for efficient diagnostic solutions will shape the industry's competitive intensity and supply-chain dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	45.56 million
Growth rate	CAGR of 17.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Danaher; Becton, Dickinson and Company; Johnson & Johnson; Roche Diagnostics; Siemens; Sysmex Corporation; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Connected Diagnostics market is poised for significant growth, driven by increasing demand for remote patient monitoring and personalized medicine. The Connected Diagnostics market size is expected to expand substantially, with a growth forecast that underscores the potential for innovative technologies to transform the healthcare landscape.

Growth Drivers2 items

Advances in internet of medical things (IoMT) and artificial intelligence (AI) are fueling the development of connected diagnostic solutions, enabling healthcare providers to access real-time patient data and make informed decisions

The growing need for remote patient monitoring and telehealth services is driving the adoption of connected diagnostics, particularly in the context of chronic disease management and population health

Restraints2 items

Concerns over data privacy and cybersecurity are hindering the widespread adoption of connected diagnostics, as healthcare providers and patients alike are wary of potential risks associated with the transmission and storage of sensitive medical information

The high cost of implementation and maintenance of connected diagnostic systems is a significant barrier to entry for many healthcare organizations, particularly smaller providers with limited resources

Opportunities2 items

The increasing focus on personalized medicine and precision diagnostics is creating new opportunities for connected diagnostics to improve patient outcomes and enhance the overall quality of care

The growing demand for point-of-care diagnostics and decentralized testing is driving innovation in the connected diagnostics market, with companies developing novel solutions that enable rapid and accurate testing in a variety of settings

Challenges2 items

The integration of connected diagnostics with existing electronic health record (EHR) systems and health information exchanges (HIEs) is a complex challenge that requires significant investment in interoperability and data standards

The need for standardization and regulatory frameworks that support the development and deployment of connected diagnostics is essential to ensuring the long-term viability and growth of the Connected Diagnostics market

Market Segmentation

Loading chart…

The Connected Diagnostics market can be segmented based on Application, which includes subtypes such as in-vitro diagnostics and imaging diagnostics. This segmentation contributes to the overall market size by highlighting the specific areas where connected diagnostics solutions are being adopted. The in-vitro diagnostics segment is expected to hold a significant share of the market, driven by the increasing demand for point-of-care testing and remote monitoring.

Another key segmentation category for the Connected Diagnostics market is Type, which comprises subtypes such as wearable sensors and mobile apps. This segmentation is crucial in understanding the Connected Diagnostics segmentation landscape, as it reveals the various types of connected devices and platforms being used to diagnose and monitor medical conditions. The wearable sensors segment is anticipated to experience rapid growth, driven by advancements in sensor technology and the rising awareness about preventive healthcare.

Connected Diagnostics Segmentation Breakdown8 items

Application

/> Clinical Research Organizations (CROs)

Clinics

Hospitals

Others

Type

/> On-Premise

Cloud-Based

Regional Insights

Loading chart…

The Connected Diagnostics market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The Asia Pacific region is anticipated to be the fastest-growing, driven by increasing adoption of connected diagnostics solutions, favorable policies, and significant investments in digital healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics of tech-savvy patients, and established infrastructure. In Europe, drivers include regulatory support, a strong healthcare system, and growing demand for remote monitoring solutions. The Asia Pacific region is driven by a large and growing population, increasing adoption of mobile health technologies, and government initiatives to improve healthcare access.

Latin America and Middle East & Africa are expected to experience significant Connected Diagnostics market growth, driven by improving infrastructure, rising demand for healthcare services, and increasing investment in digital health technologies. However, these regions also face challenges related to ecosystem maturity, regulatory frameworks, and demographics.

Competitive Landscape

The Connected Diagnostics market is moderately consolidated, with a mix of global players and local companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Connected Diagnostics competitive landscape is driven by global players, but local companies are also gaining traction. Key players are focusing on product innovation, strategic partnerships, and expansion into new regions to gain a competitive edge.

Companies in the Connected Diagnostics market are adopting various strategies such as M&A, partnerships, product launches, and R&D to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, channel strength, customization, and cost advantages. The following companies are making strategic moves to stay ahead in the market:

Abbott: regional expansion

Danaher: innovation pipeline

Becton, Dickinson and Company: premium pricing

Johnson & Johnson: OEM tie-ups

Roche Diagnostics: local manufacturing

Siemens: vertical integration

Key Connected Diagnostics Companies8 items

Abbott

Danaher

Becton, Dickinson and Company

Johnson & Johnson

Roche Diagnostics

Siemens

Sysmex Corporation

Thermo Fisher Scientific

Market Ecosystem

The Connected Diagnostics ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and channels, to downstream end users. This ecosystem creates and captures value through the development, integration, and deployment of connected diagnostic solutions, ultimately enhancing patient outcomes and streamlining healthcare services. Understanding the boundaries and interactions within this ecosystem is crucial for conducting a thorough value chain analysis.

Technology providers — develop diagnostic software and hardware

System integrators / EPCs — integrate diagnostic solutions with existing infrastructure

Distributors / channel partners — supply diagnostic equipment and services

Service providers / after-sales — offer maintenance and support for diagnostic systems

End users / buyers — utilize connected diagnostic solutions in healthcare settings

Regulators/standards bodies — establish guidelines and compliance frameworks

Data/analytics providers — analyze diagnostic data to inform healthcare decisions

The flow of value within the Connected Diagnostics ecosystem is influenced by various control points, including regulatory approvals, technology standards, and partnerships between participants. Dependency risks, such as input constraints and standards compliance, can impact the adoption and effectiveness of connected diagnostic solutions. Furthermore, switching costs, interoperability requirements, and regional differences in healthcare infrastructure and regulations can affect the ecosystem's dynamics. As the Connected Diagnostics ecosystem continues to evolve, understanding these complexities is essential for navigating the challenges and opportunities that arise.

Recent Industry Insights

The Connected Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players, such as the collaboration between major healthcare companies to enhance diagnostic capabilities. Furthermore, there have been strategic mergers and acquisitions, including the acquisition of specialized diagnostic firms to expand product portfolios.

Additionally, several product and technology launches have taken place, focusing on advanced diagnostic solutions and artificial intelligence integration. Regulatory changes have also impacted the industry, with updates to data protection laws affecting the handling of patient information. Shifts in consumer and enterprise trends have led to increased demand for personalized medicine and remote monitoring solutions. Recent funding rounds and expansions have enabled companies to invest in research and development, driving innovation in the Connected Diagnostics industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Connected Diagnostics market outlook. The market attractiveness is high, driven by the increasing demand for digital health solutions and the need for real-time data analysis. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead in the market.

The long-term outlook for the Connected Diagnostics market is positive, with the innovation landscape expected to drive growth. However, the demand–supply balance is a key risk factor, as the market is highly dependent on the availability of skilled personnel and advanced technologies. Overall, the Connected Diagnostics market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Connected Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Connected Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Connected Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Clinical Research Organizations (CROs)

6.1.2. Clinics

6.1.3. Hospitals

6.1.4. Others

6.2. Global Connected Diagnostics Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> On-Premise

6.2.2. Cloud-Based

6.3. Global Connected Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Connected Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Connected Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Connected Diagnostics Market Competition by Key Manufacturers

8.1. Global Connected Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Connected Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Danaher

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Becton, Dickinson and Company

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Johnson & Johnson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Roche Diagnostics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sysmex Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermo Fisher Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Connected Diagnostics Market

Figure 4: Global Connected Diagnostics Market: Drivers

Figure 5: Global Connected Diagnostics Market: Challenges

Figure 6: Global Connected Diagnostics Market: Trends

Figure 7: Global Connected Diagnostics Market: Opportunity

Figure 8: Global Connected Diagnostics Market: Restraint

Figure 9: Global Connected Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Connected Diagnostics Market Value (USD Million) By Region

Figure 15: Global Connected Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Connected Diagnostics Market Value (USD Million) By Region

Figure 23: Global Connected Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Connected Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Connected Diagnostics Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Connected Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Connected Diagnostics Market Value (USD Million) By Region

Table 10: Global Connected Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Connected Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Connected Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Connected Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Danaher Basic Information And Sales Area

Table 33: Danaher. Products Portfolio

Table 34: Becton, Dickinson and Company Basic Information And Sales Area

Table 35: Becton, Dickinson and Company. Products Portfolio

Table 36: Johnson & Johnson Basic Information And Sales Area

Table 37: Johnson & Johnson. Products Portfolio

Table 38: Roche Diagnostics Basic Information And Sales Area

Table 39: Roche Diagnostics. Products Portfolio

Table 40: Siemens Basic Information And Sales Area

Table 41: Siemens. Products Portfolio

Table 42: Sysmex Corporation Basic Information And Sales Area

Table 43: Sysmex Corporation. Products Portfolio

Table 44: Thermo Fisher Scientific Basic Information And Sales Area

Table 45: Thermo Fisher Scientific. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Type

Table 49: Global Market Share (%) By Type (2032)

Table 50: Global Connected Diagnostics Market Value (USD Million) By Region

Table 51: Global Connected Diagnostics Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Connected Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	45.56 million
Growth rate	CAGR of 17.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Danaher; Becton, Dickinson and Company; Johnson & Johnson; Roche Diagnostics; Siemens; Sysmex Corporation; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options